ANDA 77531, held by Watson Labs. Fosinopril Sodium.
As of Nov 16, 2026, ANDA 77531 (Fosinopril Sodium), held by Watson Labs, was first approved by FDA on Aug 31, 2006, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 31, 2006 | Original application | Approved | None posted |
| Fosinopril Sodium10MG · tablet;oral | Fosinopril Sodium | Discontinued |
| Fosinopril Sodium20MG · tablet;oral | Fosinopril Sodium | Discontinued |
| Fosinopril Sodium40MG · tablet;oral | Fosinopril Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters